Zyrtec is owned by Kenvue (the United States, NYSE: KVUE), which was separated from Johnson & Johnson on 23 August 2023.[1][2] Before Kenvue, Zyrtec was owned by Johnson & Johnson from 2006 to 2023.[2]
Zyrtec is a cetirizine antihistamine developed in Belgium and sold on prescription for years before moving over the counter in the United States in 2008. Kenvue sells the over-the-counter version in the United States; rights elsewhere are held by other companies, so the brand has different owners by market.
What Kenvue's annual report says about Zyrtec
Sentences about Zyrtec from Kenvue's latest annual filing[1], copied word for word.
In addition, certain of our OTC products, including certain Imodium , Motrin , Pepcid , and Zyrtec products, are approved by the FDA through the NDA process rather than through the monograph system.
In addition, the DEA regulates certain of our OTC products containing pseudoephedrine ("PSE"), such as Sudafed and Zyrtec-D , pursuant to the Combat Methamphetamine Epidemic Act (the "CMEA").
In addition, while our labeling and advertising claims for our monograph drug products, such as certain Benadryl , Neutrogena , and Tylenol products, and advertising claims for NDA products are not subject to approval by the FDA, labeling claims for our NDA products, such as certain Imodium , Motrin , Pepcid , and Zyrtec products, are approved by the FDA.
How often Kenvue names Zyrtec in its annual report
A plain count of the times the name appears in the text of each annual report, not counting the start of a sentence. A brand that an owner writes about more is usually one it treats as central.
Kenvue is a publicly listed company headquartered in Summit, New Jersey, United States, founded in 2023. Brandtree records 13 brands under its control, and it is listed as NYSE: KVUE.
Kenvue is the consumer health business separated from Johnson & Johnson, listed in May 2023 and fully split off that August. It holds the self-care, skin health and essential health brands that Johnson & Johnson had built up over a century. Kimberly-Clark agreed to acquire Kenvue in November 2025.
Brandtree records a controlling owner for 53 brands that began in Belgium.
19 of them (36%) are now controlled by a company headquartered in another country, Zyrtec among them.
Johnson & Johnson separated its consumer health business as Kenvue, which listed in May 2023 and was fully split off through an exchange offer completed on 23 August 2023. Tylenol, Band-Aid, Listerine, Neutrogena and Johnson's Baby all moved to the new company.
The parent company of Zyrtec is Kenvue, a publicly listed company headquartered in the United States.
Is Zyrtec Belgian or American?
⌄
Zyrtec originated in Belgium in 1987, but it is owned today by Kenvue, which is headquartered in the United States. So Zyrtec is a Belgian-origin brand under American ownership.
Since when has Kenvue owned Zyrtec?
⌄
Kenvue has owned Zyrtec since 23 August 2023.
Who owned Zyrtec before Kenvue?
⌄
Before Kenvue, Zyrtec was owned by Johnson & Johnson from 2006 until 2023.
Is Zyrtec still owned by Kenvue?
⌄
Yes. As of 9 October 2026, Zyrtec is still owned by Kenvue. The ownership record was last checked against primary sources on that date.
Sources (2) & corrections
Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.
Brandtree needs to remember this choice and does not set any other cookie unless you accept.
If you choose “Accept all”, we also use Google Analytics cookies to count visits and see which pages help, so we can improve the site.
If you choose “Accept required”, no analytics cookie is set. Google Analytics still receives a cookieless ping with the page address and your IP address. No advertising is used either way. Privacy policy